By ANDREW POLLACK from NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1fo3tMH
via IFTTT
Tuesday, February 25, 2014
InterMune Reports Successful Trial for Lung Disease Drug The company said it would apply for United States regulatory approval of pirfenidone to treat idiopathic pulmonary fibrosis, a scarring of the lungs. ANDREW POLLACK February 26, 2014 at 5:00AM http://nyti.ms/1fo3tMH The New York Times Business Day Drugs (Pharmaceuticals)
By ANDREW POLLACK from NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1fo3tMH
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
thank you